Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
Date:11/22/2011
Figure 10: Artificial Disc Replacement Market, Global, Revenue ($m), 2003?2010 20
Figure 11: Artificial Disc Replacement Market, Global, Revenue ($m), 2010?2017 21
Figure 12: Cost Benefit of Artificial Disc Replacement over Spinal Fusion 22
Figure 13: Dynamic Stabilization Market, Global, Revenue ($m), 2003?2010 24
Figure 14: Dynamic Stabilization Market, Global, Revenue ($m), 2010?2017 25
Figure 15: Interspinous Process Decompression Devices Market, Global, Revenue ($m), 2003?2010 27
Figure 16: Interspinous Process Decompression Devices Market, Global, Revenue ($m), 2010?2017 28
Figure 17: Spinal Non-Fusion Devices Market, The US, Revenue ($m), 2003?2010 30
Figure 18: Spinal Non-Fusion Devices Market, The US, Revenue ($m), 2010?2017 31
Figure 19: Spinal Non-Fusion Devices Market, Canada, Revenue ($m), 2003?2010 32
Figure 20: Spinal Non-Fusion Devices Market, Canada, Revenue ($m), 2010?2017 33
Figure 21: Spinal Non-Fusion Devices Market, The UK, Revenue ($m), 2003?2010 34
Figure 22: Spinal Non-Fusion Devices Market, The UK, Revenue ($m), 2010?2017 35
Figure 23: Spinal Non-Fusion Devices Market, Germany, Revenue ($m), 2003?2010 36
Figure 24: Spinal Non-Fusion Devices Market, Germany, Revenue ($m), 2010?2017 37
Figure 25: Spinal Non-Fusion Devices Market, France, Revenue ($m), 2003?2010 38
Figure 26: Spinal Non-Fusion Devices Market, France, Revenue ($m), 2010?2017 39
Figure 27: Spinal Non-Fusion Devices Market, Italy, Revenue ($m), 2003?2010 40
Figure 28: Spinal Non-Fusion Devices Market, Italy, Revenue ($m), 2010?2017 41
Figure 29: Spinal Non-Fusion Devices Market, Spain, Revenue ($m), 2003?2010 42
Figure 30: Spinal Non-Fusion Devices Market, Spain, Revenue ($m), 2010?2017 43
Figure 31: Spinal Non-Fusion Devices Market, China, Revenue ($m), 2003?2010 44
Figure 32: Spinal Non-Fusion Devices Market, China, Revenue
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
5. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
6. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
7. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
10. Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimers
11. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
Post Your Comments:
(Date:5/17/2013)... 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ( ... is developing new, patent-pending technologies poised to redefine how consumers ... will hold a business update teleconference and webcast for shareholders ... 2013 at 4:30 PM ET. Fuse Science, ... the call and will be joined by Rubin ...
(Date:5/17/2013)... May 17, 2013 Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 ... in both dose groups. The primary endpoint assessed the ... Consistent with data reported in previous trials, the most ... Full results will be presented at an upcoming medical ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6... Scientific,Corporation (NYSE: BSX ) today announced ... press announcements at the Cardiovascular Research Foundation,s,(CRF) ... which runs from October 20 to 25 ... be announcing a wide range of safety ...
... the novel,selective relaxant binding agent (SRBA) being developed ... neuromuscular blockade as,compared to neostigmine in the Phase ... Spectrum, faster recovery from profound neuromuscular,blockade compared to ... were presented today at the 2007 annual meeting ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 2Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 3Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 4Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia 5(Date:5/19/2013)... (PRWEB) May 19, 2013 Farming methods ... seed in the ground 10,000 years ago. Most recently, ... farm productivity by using genetically engineered seeds and by ... seeing a backlash to these techniques due to the ... chemicals and a corresponding surge in interest in organic, ...
(Date:5/19/2013)... Angeles (PRWEB) May 19, 2013 Yeast infections ... can appear in sensitive areas of the human body. A ... Yeastrol. This new formula provides a unique method of application ... new spray solution is now provided to men and women ... is naturally absorbed in the body through food and is ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Beginning Wednesday, May ... Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" and ... RRVBC will provide hot dogs and all the fixin's ... slushies each day throughout the summer. “Donors are our lifeline. ... a stable and adequate blood supply. This is a ...
(Date:5/19/2013)... fender benders and serious car accidents are common sights ... to respond appropriately to the situation. According to ... 2010, accidents, including car accidents, are the fifth leading ... automobile accident-related deaths cost over $70 billion ... and passengers receive treatment in an emergency room every ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
Breaking Medicine News(10 mins):Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2[0] Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics[0] A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount[0] Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer[0] Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash[0] Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’
... Two methods that permit scientists to examine ... months release of Cold Spring Harbor Protocols . ... www.cshprotocols.org ), describe how to fluorescently tag cells in ... sophisticated imaging methods, permit scientists to visualize even subtle ...
... Splash with Las Vegas and Tucson Marathon Runners, ... ibuprofen,before an event to prevent inflammation and pain, but ... studies by researchers at,Appalachian State University and Vanderbilt University, ... that taking ibuprofen,before exercise may be unhealthy in the ...
... 3 As momentum continues to,build on the ... in Medicare, the Pharmaceutical Care Management Association,(PCMA) today ... J. Lyle,Bootman, Ph.D., Sc.D., Last year, Dr. ... recommended that all physicians begin using e-prescribing by,2010 ...
... Home Front Needs of Families with Deployed Service Members ... ... Alliance will present $15,000 to the Missouri National Guard -,Missouri Military Family Relief ... and their families., Don Brown, market vice president for the central market ...
... HUNTSVILLE, Ala., Dec. 3 Operon,Biotechnologies, Eurofins MWG ... Genomics network - announced today that they have ... new worldwide leader in the competitive,custom oligonucleotide market. ... of,the art high-throughput production facilities in all major ...
... and CEO retires; Mike Gallagher, President and ... MIAMI, Dec. 3 AvMed Health Plans ... announced plans to retire December 31,2007. As a ... parent company,SantaFe HealthCare, who already has overall leadership ...
Cached Medicine News:Health News:Cold Spring Harbor Protocols features innovative methods for embryology research 2Health News:Marathoners Share Tom Brady and LaDainian Tomlinson Pain Relief Affinity 2Health News:TriWest Contributes $15,000 to Missouri National Guard Fund 2Health News:MWG and Operon Are Joining Forces 2Health News:AvMed Announces Senior Leadership Changes 2Cold Spring Harbor Protocols features innovative methods for embryology researchMarathoners Share Tom Brady and LaDainian Tomlinson Pain Relief AffinityPCMA Launches New Round of E-Prescribing AdvertisingTriWest Contributes $15,000 to Missouri National Guard FundMWG and Operon Are Joining ForcesAvMed Announces Senior Leadership Changes
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |